# Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression

> **NCT00069927** · PHASE2 · TERMINATED · sponsor: **University of South Florida** · enrollment: 12 (actual)

## Conditions studied

- Depression
- Neurotoxicity
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Adderall-XR®
- **DRUG:** Concerta®

## Key facts

- **NCT ID:** NCT00069927
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-08
- **Primary completion:** 2006-06
- **Final completion:** 2006-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility
- **Last updated:** 2014-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069927, "Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00069927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*